Supernus Pharmaceuticals CEO Jack Khattar's 2018 pay jumps 30% to $7.2M
Supernus Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 24, 2020
Supernus Pharmaceuticals reported fiscal year 2018 executive compensation information on April 24, 2020.
In 2018, six executives at Supernus Pharmaceuticals received on average a compensation package of $2.1M, a 15% increase compared to previous year.
Average pay of disclosed executives at Supernus Pharmaceuticals
Jack A. Khattar, Chief Executive Officer, received $7.2M in total, which increased by 30% compared to 2017. 80% of Khattar's compensation, or $5.8M, was in option awards. Khattar also received $635K in non-equity incentive plan, $719K in salary, as well as $63K in other compensation.
For fiscal year 2018, the median employee pay was $131,026 at Supernus Pharmaceuticals. Therefore, the ratio of Jack A. Khattar's pay to the median employee pay was 55 to one.
Stefan K.F. Schwabe, Chief Medical Officer, received a compensation package of $1.3M, which increased by 2% compared to previous year. 54% of the compensation package, or $696K, was in option awards.
Gregory S. Patrick, Chief Financial Officer, earned $1.2M in 2018, a 3% increase compared to previous year.
Padmanabh P. Bhatt, Chief Scientific Officer, received $1.2M in 2018, which increases by 16% compared to 2017.
Victor Vaughn, Former Senior Vice President of Sales and Marketing, earned $943K in 2018, a 22% decrease compared to previous year.
Tami Martin, R.N., Senior Vice President, Regulatory Affairs, received $725K in 2018, which increases by 8% compared to 2017.
Related executives
Tami RN
Supernus Pharmaceuticals
Senior Vice President, Regulatory Affairs
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
Padmanabh Bhatt
Supernus Pharmaceuticals
Chief Scientific Officer
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
Victor Vaughn
Supernus Pharmaceuticals
Former Senior Vice President of Sales and Marketing
You may also like
Source: SEC filing on April 24, 2020.